Stockscreener 앱 받기
11.38
1.88%
0.21
전일 마감가:
$11.17
열려 있는:
$11.32
하루 거래량:
2.62M
Relative Volume:
1.47
시가총액:
$1.47B
수익:
$628.25M
순이익/손실:
$-78.55M
주가수익비율:
-18.35
EPS:
-0.62
순현금흐름:
$-29.73M
1주 성능:
-0.35%
1개월 성능:
-11.99%
6개월 성능:
+82.37%
1년 성능:
-18.19%
1일 변동 폭
$11.17
$11.61
1주일 범위
$11.12
$11.79
52주 변동 폭
$4.72
$14.73
Neogenomics Inc Stock (NEO) Company Profile
명칭
Neogenomics Inc
전화
(239) 768-0600
주소
9490 NEOGENOMICS WAY, FORT MYERS, FL
Compare NEO vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
11.38 | 1.45B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-29 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 개시 | Guggenheim | Neutral |
| 2025-04-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 개시 | Jefferies | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-08-21 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-02-24 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-02-01 | 업그레이드 | Needham | Hold → Buy |
| 2022-08-26 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-22 | 다운그레이드 | Needham | Buy → Hold |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-03-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-29 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 재개 | Stephens | Overweight |
| 2021-12-16 | 개시 | Cowen | Outperform |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-25 | 재개 | Needham | Buy |
| 2021-02-25 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-12-11 | 재개 | BTIG Research | Buy |
| 2020-10-28 | 재확인 | Needham | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-08-28 | 개시 | Guggenheim | Buy |
| 2020-07-29 | 재확인 | Needham | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Buy |
| 2020-04-21 | 재개 | Stephens | Overweight |
| 2020-03-02 | 재개 | Craig Hallum | Buy |
| 2020-02-28 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-01 | 재확인 | Needham | Buy |
| 2019-03-29 | 재확인 | Needham | Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-10-24 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 개시 | Leerink Partners | Outperform |
| 2018-05-02 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-08-24 | 개시 | Gabelli & Co | Buy |
| 2016-12-15 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics launches PanTracer Pro for advanced-stage solid tumors - Traders Union
Will NeoGenomics Inc. stock hit new highs in YEARJuly 2025 Review & Technical Confirmation Trade Alerts - mfd.ru
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection - Business Wire
Buybacks Report: Is NeoGenomics Inc. forming bullish engulfing patternsJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - mfd.ru
What’s the analyst consensus on NeoGenomics Inc.Weekly Trade Summary & AI Driven Price Predictions - mfd.ru
NeoGenomics (NEO) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
What are NeoGenomics Inc.’s recent SEC filings showingWeekly Volume Report & Weekly Top Performers Watchlists - mfd.ru
NeoGenomics sees Q4 revenue of about $190M - MSN
Trading Systems Reacting to (NEO) Volatility - Stock Traders Daily
Update Recap: Is Capital One Capital II LLC Preferred Security stock a top performer YTDJuly 2025 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
165,890 Shares in NeoGenomics, Inc. $NEO Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Aug Movers: Can LCFYW sustain its profitability2025 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
US Stocks Recap: Can NeoGenomics Inc deliver alphaJuly 2025 Pullbacks & Reliable Price Breakout Alerts - baoquankhu1.vn
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - BioSpace
Press Release: NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - 富途牛牛
NeoGenomics: Distribution Moat In Community Oncology (NASDAQ:NEO) - Seeking Alpha
Should NeoGenomics’ CFO Transition and Early 2025 Revenue Signals Require Action From NEO Investors? - simplywall.st
Published on: 2026-01-25 10:30:50 - baoquankhu1.vn
Don't Ignore The Insider Selling In NeoGenomics - Sahm
Neogenomics pres. Stone sells $277k in NEO stock By Investing.com - Investing.com Nigeria
NeoGenomics (NASDAQ:NEO) COO Sells 22,128 Shares of Stock - MarketBeat
Neogenomics pres. Stone sells $277k in NEO stock - Investing.com
Anatomic Pathology Market Innovations and Key Players: Agilent - openPR.com
Volume Report: Why is NeoGenomics Inc stock going upEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
NeoGenomics, Inc. (NEO) Stock Analysis: Unpacking a 12.81% Upside Potential Amidst Healthcare Diagnostics Growth - DirectorsTalk Interviews
Is NeoGenomics Inc. stock overvalued or fairly pricedFinancial Sector Performance & Target Triple-Digit Stock Opportunities - bollywoodhelpline.com
Aug Sentiment: Why is NeoGenomics Inc stock going upRate Cut & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
How NeoGenomics’ (NEO) CFO Transition and Double‑Digit Revenue Guidance Has Changed Its Investment Story - simplywall.st
Pullback Watch: Should you buy the dip on NeoGenomics IncJuly 2025 Trade Ideas & Smart Swing Trading Alerts - baoquankhu1.vn
NeoGenomics (NASDAQ:NEO) Raised to Strong-Buy at Zacks Research - MarketBeat
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and NeoGenomics (NEO) - The Globe and Mail
Aug Volume: Is NeoGenomics Inc stock undervalued right nowQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
NeoGenomics names incoming CFO amid revenue growth - Gulfshore Business
NeoGenomics, Inc. (NEO) Stock Analysis: Assessing A 16.59% Potential Upside - DirectorsTalk Interviews
NeoGenomics forecasts 11% revenue growth for Q4 2025, names new CFO - Investing.com Nigeria
NeoGenomics (NASDAQ:NEO) Shares Down 7.4%Here's What Happened - MarketBeat
NeoGenomics, Inc. Announces Chief Financial Officer Changes - marketscreener.com
NeoGenomics, Inc. Announces Executive Changes - marketscreener.com
Fort Myers-based NeoGenomics expects big revenue increase for 2025 - news-press.com
NeoGenomics (NASDAQ:NEO) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors - The National Law Review
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue - PharmiWeb.com
NeoGenomics prelim Q4 revenue slightly beats estimates, names insider as CFO - TradingView
NeoGenomics announces board changes to support future growth - MSN
How NeoGenomics Inc. stock reacts to oil prices2025 Biggest Moves & Weekly Return Optimization Plans - Улправда
Will NeoGenomics Inc. stock attract more institutional investorsMarket Risk Analysis & Daily Risk Controlled Trade Plans - Улправда
Will NeoGenomics Inc. stock benefit from infrastructure spending2025 Macro Impact & Fast Moving Trade Plans - Улправда
Neogenomics Shares Surge on Strategic and Legal Developments - AD HOC NEWS
Will NeoGenomics Inc. stock outperform international peersQuarterly Market Summary & Smart Money Movement Alerts - Улправда
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift - Yahoo Finance
Neogenomics Inc (NEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.13%
자본화:
|
볼륨(24시간):